Rukobia (fostemsavir) is a brand-name extended-release (ER) oral tablet that’s prescribed for HIV in certain adults. If you have problems with side effects from Rukobia, talk with your doctor or ...

Only one attachment inhibitor, known as fostemsavir (Rukobia), is currently available. The FDA approved this drug in July 2020, making it one of the newest HIV drugs on the market. Rukobia is used ...

The FDA has approved Rukobia, a first-in-class drug from ViiV Healthcare intended for older people with HIV, who have been on antiretroviral therapy (ART) for so long it is starting to fail.

The injectable therapy will compete with Rukobia (fostemsavir) from ViiV Healthcare, Gilead's biggest rival in the HIV market, which was approved for MDR HIV by the FDA in 2020. Rukobia is dosed ...